相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins
Samagya Banskota et al.
CELL (2022)
The DMD gene and therapeutic approaches to restore dystrophin
Fernanda Fortunato et al.
NEUROMUSCULAR DISORDERS (2021)
Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
F. Chemello et al.
SCIENCE ADVANCES (2021)
Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
Mohammadsharif Tabebordbar et al.
CELL (2021)
Prime editing - an update on the field
Janine Scholefield et al.
GENE THERAPY (2021)
Efficient precise in vivo base editing in adult dystrophic mice
Li Xu et al.
NATURE COMMUNICATIONS (2021)
The promise and challenge of therapeutic genome editing
Jennifer A. Doudna
NATURE (2020)
Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies
Joshua J. Todd et al.
NEUROLOGY (2020)
CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
Dan Wang et al.
CELL (2020)
Correction of muscular dystrophies by CRISPR gene editing
Francesco Chemello et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Therapeutic applications of trans-splicing
Elizabeth M. Hong et al.
BRITISH MEDICAL BULLETIN (2020)
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone et al.
NATURE BIOTECHNOLOGY (2020)
After Third Death, Audentes' AT132 Remains on Clinical Hold
Alex Philippidis
HUMAN GENE THERAPY (2020)
Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature
Tokunbor A. Lawal et al.
SKELETAL MUSCLE (2020)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
ClinVar: improving access to variant interpretations and supporting evidence
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2018)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
Chengzu Long et al.
SCIENCE (2016)
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Mohammadsharif Tabebordbar et al.
SCIENCE (2016)
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Christopher E. Nelson et al.
SCIENCE (2016)
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor et al.
NATURE (2016)
Full-Length Dystrophin Reconstitution with Adeno-Associated Viral Vectors
William Lostal et al.
HUMAN GENE THERAPY (2014)
Triple Trans-Splicing Adeno-Associated Virus Vectors Capable of Transferring the Coding Sequence for Full-Length Dystrophin Protein into Dystrophic Mice
Taeyoung Koo et al.
HUMAN GENE THERAPY (2014)
Exon Skipping as a Therapeutic Strategy Applied to an RYR1 Mutation with Pseudo-Exon Inclusion Causing a Severe Core Myopathy
John Rendu et al.
HUMAN GENE THERAPY (2013)
Allele-Specific Gene Silencing in Two Mouse Models of Autosomal Dominant Skeletal Myopathy
Ryan E. Loy et al.
PLOS ONE (2012)
LOVD v.2.0: The Next Generation in Gene Variant Databases
Ivo F. A. C. Fokkema et al.
HUMAN MUTATION (2011)
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors
Y Lai et al.
NATURE BIOTECHNOLOGY (2005)
HSV-1 amplicon vectors are a highly efficient gene delivery system for skeletal muscle myoblasts and myotubes
Y Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2000)
分享论文
